Compare · HIMS vs NAKA
HIMS vs NAKA
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Nakamoto Inc. (NAKA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and NAKA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.60B, about 107.6x NAKA ($70.7M).
- Over the past year, HIMS is down 34.8% and NAKA is down 99.1% - HIMS leads by 64.3 points.
- HIMS has been more active in the news (7 items in the past 4 weeks vs 3 for NAKA).
- HIMS has more recent analyst coverage (25 ratings vs 3 for NAKA).
- Company
- Hims & Hers Health Inc.
- Nakamoto Inc.
- Price
- $32.86-2.41%
- $4.10+2.76%
- Market cap
- $7.60B
- $70.7M
- 1M return
- +4.42%
- -8.48%
- 1Y return
- -34.76%
- -99.07%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2024
- News (4w)
- 7
- 3
- Recent ratings
- 25
- 3
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest HIMS
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)
Latest NAKA
- Clear Street Executes First Bitcoin Depositary Receipt Trade Through Prime Brokerage Platform
- Nakamoto Announces Closing of Legacy Healthcare Clinics
- Nakamoto Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Nakamoto Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Nakamoto Strengthens Capital Structure Through Debt Reduction, Refinancing, and Share Repurchase Authorization
- Amendment: SEC Form SCHEDULE 13D/A filed by Nakamoto Inc.
- Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock
- Chief Executive Officer Bailey David F bought $309,516 worth of shares (55,115 units at $5.62), increasing direct ownership by 2% to 3,175,476 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $683,112 worth of shares (136,333 units at $5.01), increasing direct ownership by 5% to 3,120,361 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits